Comment on: ALBAN (GETUG-AFU 37): a phase III, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)
Saved in:
| Title: | Comment on: ALBAN (GETUG-AFU 37): a phase III, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC) |
|---|---|
| Authors: | Contieri, R.1 (AUTHOR) contieri.ro@gmail.com, Mollica, V.2 (AUTHOR), Shariat, S.F.3 (AUTHOR), Pradere, B.4 (AUTHOR) |
| Source: | Annals of Oncology. May2026, Vol. 37 Issue 5, p747-749. 3p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
